Ausgabe 6/2022
Including PIH articles on Novel technologies and innovative treatments in multiple myeloma
Inhalt (21 Artikel)
Guest Editorial: Innovation will be a bridge to cure in patients with multiple myeloma?
Hiroyuki Takamatsu
Multiple myeloma with high-risk cytogenetics and its treatment approach
Ichiro Hanamura
Progress of modern imaging modalities in multiple myeloma
Toshiki Terao, Kosei Matsue
Bringing mass spectrometry into the care of patients with multiple myeloma
David L. Murray
Higher incidence of thrombocytopenia during obinutuzumab plus bendamustine therapy for untreated follicular lymphoma: a retrospective analysis by the Okayama Hematology Study Group
Yuki Fujiwara, Tomohiro Urata, Daigo Niiya, Tomofumi Yano, Yuichiro Nawa, Isao Yoshida, Toshi Imai, Kazutaka Sunami, Soichiro Fujii, Daisuke Ennishi, Yoshinobu Maeda, Yasushi Hiramatsu
T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia
Fumihiro Kawakami, Toru Kawakami, Taku Yamane, Masae Maruyama, Jun Kobayashi, Sayaka Nishina, Hitoshi Sakai, Yumiko Higuchi, Kazutoshi Hamanaka, Makoto Hirokawa, Shinji Nakao, Hideyuki Nakazawa, Fumihiro Ishida
The balance of comprehensive coagulation and fibrinolytic potential is disrupted in patients with moderate to severe COVID-19
Tomoko Onishi, Naruto Shimonishi, Masahiro Takeyama, Shoko Furukawa, Kenichi Ogiwara, Yuto Nakajima, Kei Kasahara, Kenji Nishio, Kiyomi Yoshimoto, Satoki Inoue, Masahiko Kawaguchi, Hidetada Fukushima, Yoshihiko Saito, Hitoshi Yoshiji, Shigeo Muro, Kazuhiko Tsuruya, Sadanori Okada, Kazuma Sugie, Ryuji Kawaguchi, Toshiya Nishikubo, Masaharu Yamazaki, Yukio Oda, Toshiki Kawabe, Kengo Onishi, Tomohisa Nishio, Keiji Nogami
Safety profile of bosutinib in Japanese versus non-Japanese patients with chronic myeloid leukemia: a pooled analysis
Naoto Takahashi, Jorge E. Cortes, Emiko Sakaida, Kenichi Ishizawa, Takaaki Ono, Noriko Doki, Itaru Matsumura, Valentín García-Gutiérrez, Gianantonio Rosti, Chiho Ono, Masayuki Ohkura, Yusuke Tanetsugu, Andrea Viqueira, Tim H. Brümmendorf
Erythroblast predominance without CD41/cyCD41-positive blasts predicts favorable prognosis in patients with myelodysplastic syndromes and acute myeloid leukemias treated with azacitidine
Akihito Matsuoka, Masaki Tanibuchi, Ieharu Yamazaki, Teruhisa Taoka
Coadministration with bendamustine restores the antitumor activity of obinutuzumab in obinutuzumab-resistant tumors
Yoriko Yamashita-Kashima, Keigo Yorozu, Takaaki Fujimura, Natsumi Kawasaki, Mitsue Kurasawa, Shigeki Yoshiura, Naoki Harada, Osamu Kondoh, Yasushi Yoshimura
Unrelated cord blood transplantation for adult-onset EBV-associated T-cell and NK-cell lymphoproliferative disorders
Yasushi Onishi, Koichi Onodera, Noriko Fukuhara, Hiroki Kato, Satoshi Ichikawa, Tohru Fujiwara, Hisayuki Yokoyama, Minami Yamada-Fujiwara, Hideo Harigae
The safety and efficacy of hematopoietic stem cell mobilization using biosimilar filgrastim in related donors
Riko Tsumanuma, Eijiro Omoto, Hiroaki Kumagai, Yuta Katayama, Koji Iwato, Go Aoki, Yuji Sato, Yutaka Tsutsumi, Nobuhiro Tsukada, Masaki Iino, Yoshiko Atsuta, Yoshihisa Kodera, Shinichiro Okamoto, Hiromasa Yabe
JACLS ALL-02 SR protocol reduced-intensity chemotherapy produces excellent outcomes in patients with low-risk childhood acute lymphoblastic leukemia
Yoshihiro Takahashi, Hisashi Ishida, Toshihiko Imamura, Kosuke Tamefusa, Souichi Suenobu, Ikuya Usami, Keiko Yumura-Yagi, Daiichiro Hasegawa, Shinichiro Nishimura, Nobuhiro Suzuki, Yoshiko Hashii, Takao Deguchi, Akiko Moriya-Saito, Yoshiyuki Kosaka, Koji Kato, Ryoji Kobayashi, Hirohide Kawasaki, Hiroki Hori, Atsushi Sato, Toru Kudo, Tatsutoshi Nakahata, Megumi Oda, Junichi Hara, Keizo Horibe
Paravertebral extramedullary hematopoiesis in a case of myelodysplastic syndrome with ring sideroblasts and an SF3B1 mutation
Chie Asou, Tomoya Maeda, Maho Ishikawa, Daisuke Okamura, Mika Kohri, Naoki Takahashi, Kunihiro Tsukasaki, Hirozo Sakaguchi, Tsugumi Satoh, Hidekazu Kayano, Akira Matsuda, Norio Asou
Bosutinib-induced lung injury: a report of two cases and literature review
Naoki Watanabe, Tomoiku Takaku, Yutaka Tsukune, Hajime Yasuda, Tomonori Ochiai, Kohei Yamada, Hiroki Nakazawa, Saori Hotta, Takayasu Nishimaki, Haruhi Takagi, Kazuhisa Takahashi, Norio Komatsu, Miki Ando
Hemophilic pseudotumor of the maxillary sinus in an inhibitor-positive patient with hemophilia A receiving emicizumab: a case report
Fuko Kawahara, Rie Shirayama, Takuma Ito, Koichi Oshida, Tetsuji Sato, Koichi Kusuhara
Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination
Tohru Inaba, Keita Okumura, Chika Maekura, Ayako Muramatsu, Tsutomu Kobayashi, Junya Kuroda, Yoko Nukui
Interactions with the CYP3A inhibitor voriconazole differ between extended-LCP- and immediate-release tacrolimus formulations
Gerold Thölking, Ulrich Jehn, Stefan Reuter
Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination
Tohru Inaba, Keita Okumura, Chika Maekura, Ayako Muramatsu, Tsutomu Kobayashi, Junya Kuroda, Yoko Nukui